A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni Fontecedro, Urania G. Dafni et al. · Annals of Oncology · 2020

Cited by 271 works. doi:10.1016/j.annonc.2020.09.009 Open-access PDF

Authors

References